Best FDA-Cleared Migraine Devices in 2026

Migraine affects 39 million Americans and over one billion people worldwide, yet pharmaceutical treatments are not the right fit for everyone. FDA-cleared neuromodulation devices offer a drug-free treatment format that targets nerve pathways involved in migraine without adding another medication to a person’s routine.

Finding the right device means understanding differences in technology, treatment modes, accessibility, cleared uses, and individual clinical considerations. The Cefaly device stands out as a pioneering FDA-cleared option, with over 20 years of research and availability without a prescription in the U.S., Canada, the EU, and other countries. 

Key Takeaways

• Cefaly combines prescription-free accessibility and dual-mode treatment with availability without a prescription in the U.S., Canada, the EU, and other countries, acute and preventive programs, and 79% of patients experiencing significant pain reduction after one hour of acute treatment
• FDA clearance matters because it distinguishes medical devices from general wellness products; for many Class II devices, 510(k) clearance is based on FDA review of safety and effectiveness information, including substantial equivalence to a legally marketed predicate device
• e-TNS technology targets the trigeminal nerve, the primary pathway for migraine pain, through precise electrical impulses delivered through an electrode positioned on the forehead, between and just above the eyebrows
• Drug-free options do not add another medication to a person’s routine, which can be relevant for people concerned about medication overuse or drug interactions
• FDA-cleared migraine devices use different nerve pathways, treatment formats, age indications, and access models

Understanding FDA-Cleared Neuromodulation for Migraine Treatment

FDA clearance for Class II migraine devices is based on FDA review of safety and effectiveness information, including substantial equivalence to a legally marketed predicate device. Clinical data may be included when needed to support substantial equivalence.

Neuromodulation devices deliver controlled electrical or magnetic impulses to specific nerve pathways involved in migraine. The trigeminal nerve is located under the skin of the forehead and serves as the primary pathway for migraine pain. Cefaly stimulates nerve endings through an electrode positioned on the forehead, between and just above the eyebrows.

External trigeminal nerve stimulation (e-TNS) works by delivering precise electrical impulses through the skin to stimulate branches of the trigeminal nerve. This approach differs from TENS units designed for body pain. e-TNS devices like Cefaly are specifically engineered for cranial use with parameters designed for the trigeminal nerve system.

What Does FDA Clearance Mean for Migraine Devices?

FDA 510(k) clearance establishes that a device is substantially equivalent to a legally marketed predicate device and meets applicable safety and effectiveness requirements. For Class II medical devices like migraine neuromodulators, this can involve review of factors such as:

• Device design and labeling for the intended use
• Safety and performance information relevant to the device type
• Quality and manufacturing controls that support consistent device performance
• Adverse event reporting and post-market responsibilities for ongoing safety monitoring

Healthcare providers and patients can compare FDA-cleared migraine devices using neutral, non-clinical factors such as cleared indication, age indication, device placement, prescription status, treatment format, and individualized clinical considerations.

1) Cefaly

Best For: Adults seeking a prescription-free, non-invasive, drug-free migraine device for both acute relief support and preventive treatment support

Access: FDA-cleared in the U.S. and available without a prescription in the U.S., Canada, the EU, and other countries

Treatment Format: Reusable external trigeminal nerve stimulation device with a 60-minute Acute program and a 20-minute daily Prevent program

The Cefaly device represents over two decades of migraine research and development. Cefaly was FDA-cleared for episodic migraine prevention in 2014 and acute migraine treatment in 2017. Cefaly’s preventive indication is for episodic migraine in patients 18 years of age or older. Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries.

Cefaly is a medical device indicated for the acute treatment of migraine with or without aura in patients 18 years of age or older and the preventative treatment of episodic migraine in patients 18 years of age or older.

Key Features

• Dual treatment modes: Acute mode is a 60-minute session for use during a migraine attack, while Prevent mode is a 20-minute daily session for episodic migraine prevention
• Bluetooth connectivity: The Cefaly Migraine Relief app enables device control, treatment tracking, and health wearables integration
• Smart intensity adjustment: Stimulation gradually increases at the start of treatment so users can set a comfortable intensity level
• HSA/FSA eligible: Cefaly qualifies as a pre-tax healthcare expense for eligible accounts

Why Cefaly Stands Out

Cefaly earned designation as the #1 neuromodulation device prescribed by Veterans Health Administration providers in 2025, with 21,593 devices covered in 2024 alone. Veterans experience migraine at more than twice the rate of the general population, making migraine care an important issue in this population.

Clinical studies report no serious adverse effects. Minor side effects can include sleepiness during or after treatment, post-session headache, forehead skin redness, or skin irritation. Because Cefaly is drug-free, it does not add another medication to a person’s migraine routine.

2) Nerivio

Best For: Families seeking a device cleared for children as young as 8 years old

Access: Prescription required

Treatment Format: Remote electrical neuromodulation armband with app-controlled treatment sessions

Nerivio uses remote electrical neuromodulation (REN) technology, worn as an armband on the upper arm rather than the head. In November 2024, the FDA expanded Nerivio’s age indication to 8 years and older.

Key Features

• Upper arm placement: Worn on the upper arm instead of the forehead
• Smartphone-controlled: Treatment is administered through a mobile app
• 45-minute sessions: Used for both acute treatment and prevention
• Insurance access: Coverage may vary depending on plan and eligibility

Considerations

• Requires a prescription
• Treatment sessions are 45 minutes
• Cleared for ages 8+

3) gammaCore Sapphire

Best For: Patients researching a device cleared for more than one headache disorder

Access: Prescription required

Treatment Format: Handheld non-invasive vagus nerve stimulation device applied to the side of the neck

gammaCore Sapphire uses non-invasive vagus nerve stimulation (nVNS), targeting the vagus nerve on the side of the neck rather than the trigeminal pathway. It is FDA-cleared for migraine and cluster headache treatment.

Key Features

• Short treatment format: Sessions are typically measured in minutes
• Neck placement: Handheld device applied to the side of the neck
• Multiple indications: FDA-cleared for migraine, cluster headache, hemicrania continua, and paroxysmal hemicrania
• VA coverage available: Coverage may be available for eligible veterans

Considerations

• Requires a prescription
• Pricing varies and may require contacting the manufacturer
• Cleared for ages 12+

4) SAVI Dual

Best For: Patients researching magnetic stimulation without adhesive electrode contact

Access: Prescription required

Treatment Format: Single-pulse transcranial magnetic stimulation device held at the back of the head

SAVI Dual, formerly SpringTMS, uses single-pulse transcranial magnetic stimulation (sTMS). The device is held at the back of the head and delivers rapid magnetic pulses.

Key Features

• Pulse-based treatment: Treatment is delivered through brief magnetic pulses
• No adhesive electrodes: Magnetic stimulation does not require forehead electrode contact
• Unlimited treatments: Monthly subscription includes unlimited pulse usage
• VA coverage available: Coverage may be available for eligible veterans

Considerations

• Ongoing subscription model
• Requires prescription
• Cleared for ages 12+
• Device is larger than some other options

5) Relivion MG

Best For: Adults researching acute migraine treatment with dual nerve pathway targeting

Access: Prescription required

Treatment Format: Headset-style external combined occipital and trigeminal neurostimulation device

Relivion MG uses external combined occipital and trigeminal neurostimulation (eCOT-NS). The headset-style device wraps around the head with electrodes on both the forehead and the back of the head.

Key Features

• Dual-pathway stimulation: Targets trigeminal and occipital nerve pathways
• Headset design: Includes forehead and occipital electrodes
• Smartphone app: Companion app supports treatment tracking
• 20-60 minute sessions: Session length varies by treatment use

Considerations

• Acute treatment only
• Requires prescription
• Cleared for ages 18+ only
• The initial 60-day Therapy Program fee is listed at $200 after prescription acquisition, with additional costs dependent on the program path

6) HeadaTerm 2

Best For: Budget-conscious patients researching preventive e-TNS treatment

Access: No prescription required

Treatment Format: External trigeminal nerve stimulation device for preventive treatment

HeadaTerm 2 is an e-TNS device and was cleared by the FDA in April 2024. It offers a lower entry price for FDA-cleared neuromodulation.

Key Features

• OTC availability: No prescription required
• Includes headband: Elastic band helps secure device placement
• 60-minute daily sessions: Designed for preventive use

Considerations

• Preventive treatment only
• No Bluetooth connectivity or app integration
• Cleared for ages 18+

Drug-Free Migraine Relief: Why It Matters

Pharmaceutical migraine treatments are effective for many patients, but medication routines can involve individualized considerations. Medication overuse of headache can develop when some acute headache medications are used too frequently. Drug interactions can also matter for people taking multiple medications.

Neuromodulation devices offer a drug-free treatment format, so they do not add another medication to a person’s migraine routine. This can be relevant for:

• People who do not respond adequately to medications or have tried multiple medication options
• People who have difficulty tolerating medication side effects
• People managing multiple prescriptions where drug interactions may be a consideration
• People researching non-invasive, drug-free options as part of a broader migraine-management plan

Talk to your healthcare provider before using Cefaly if you are pregnant, breastfeeding, have an implanted device, have a complex medical history, are changing medications, or are experiencing new or unusual symptoms. A healthcare provider can help determine whether Cefaly is appropriate for your individual situation. Cefaly lists contraindications for people with implanted metallic or electronic devices in the head, a cardiac pacemaker, or an implanted or wearable defibrillator.

Why Cefaly Is a Strong Option for Drug-Free Migraine Relief 

When evaluating FDA-cleared migraine devices, Cefaly stands out for several practical reasons:

Pioneer Status and Research Depth: As an early FDA-cleared migraine neuromodulation device, Cefaly has accumulated over 20 years of research, more than 12 clinical trials, and 18 peer-reviewed publications. This gives patients and clinicians a substantial Cefaly-specific evidence base to review.

Prescription-Free Access: Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries. In the U.S., this removes the prescription step from access to an FDA-cleared migraine device.

Dual Treatment Modes: Cefaly includes both a 60-minute Acute program for migraine attacks and a 20-minute daily Prevent program for preventive treatment. This allows one reusable device to support both acute and preventive treatment formats.

Cefaly Prevention Data: In the PREMICE study, 38.1% of patients achieved a 50% or greater reduction in migraine days, and acute medication intake decreased by 36.6% after three months.

Safety Profile: Cefaly clinical studies report no serious adverse effects. Minor side effects can include sleepiness, post-session headache, forehead skin redness, or skin irritation. 

Veteran Use: The designation as #1 device prescribed by VA providers shows Cefaly’s use within the VA healthcare system for eligible veterans.

Satisfaction Guarantee: If a customer is not satisfied with Cefaly, the device can be returned for a refund within 90 calendar days of the product delivery date when purchased directly fromthe official website. Individual clinical results can vary.

Cefaly’s how it works page explains the device format, treatment programs, and electrode placement in more detail.

Frequently Asked Questions

Is Cefaly covered by insurance?

Cefaly qualifies as an HSA/FSA eligible expense, allowing eligible users to use pre-tax healthcare funds for purchase. Commercial insurance coverage varies by plan. For veterans, Cefaly may be covered through the VA healthcare system, where it has been named the #1 neuromodulation device prescribed by Veterans Health Administration providers. The insurance information page provides more details on coverage options.

How quickly can Cefaly results appear?

For acute treatment, 79% of patients experienced significant pain reduction after one hour of treatment in a clinical trial. For prevention, the PREMICE study showed reductions in monthly headache days after three months of daily 20-minute Prevent mode sessions. Individual clinical results can vary.

Are there any side effects from using Cefaly?

Clinical studies report no serious adverse effects. Minor side effects can include sleepiness during or after treatment, post-session headache, forehead skin redness, or skin irritation. People with safety concerns, skin reactions, or unusual symptoms can discuss them with a healthcare provider.

Can Cefaly be used with other migraine medications?

Cefaly is drug-free and can be discussed as part of a broader migraine-management plan. Medication changes are individualized clinical decisions and are best discussed with a healthcare provider. Cefaly lists contraindications for people with implanted metallic or electronic devices in the head, a cardiac pacemaker, or an implanted or wearable defibrillator.

How often do Cefaly adhesive electrodes need to be replaced?

Electrodes are reusable and typically last for multiple sessions with proper care. Electrode lifespan can vary based on skin type, storage, and frequency of use. Electrode subscriptions offer 5% off, free shipping, and customizable delivery frequency.

How does the Cefaly app support migraine tracking?

The Cefaly app supports treatment control, session monitoring, migraine logging, trigger tracking, health wearables integration, and personalized reports that can be shared during healthcare provider appointments. App features may vary by region and compatible device availability.